US Approves First Cannabis-Based Drug
The U.S. health regulator approved GW Pharmaceuticals Plc’s epilepsy
treatment on Monday, making it the first cannabis-based drug to win
approval in the country and opening floodgates for more research into
the medicinal properties of cannabis.
The drug’s approval permits its use in patients aged two years and older with Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), rare childhood-onset forms of epilepsy that are among the most resistant to treatment.
The drug’s approval permits its use in patients aged two years and older with Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), rare childhood-onset forms of epilepsy that are among the most resistant to treatment.
“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said Food and Drug Administration Commissioner Scott Gottlieb.
The drug, Epidiolex, is made up of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant, and contains less than 0.1 percent of tetrahydrocannabinol (THC), the psychoactive component that makes people high.
Posted in Health & Physical Fitness
Related
- Health Benefits of Kunu (Millet Drink)
- Man Has HUNDREDS Of Blackheads Squeezed From Face After 'Years Of Not Washing Properly [Photos]
- Ebola Patients Slip Out Of Congo Hospital
- Do You Know That Men Refuse Sex More Than Women? READ IT HERE...
- Fresh Ebola Outbreak: All Passengers To Now Go Through Medical Screening
No comments